Paper 13311-10
Lung cancer detection in a high-risk screening cohort using machine learning-assisted ATR-FTIR spectroscopy of serum
27 January 2025 • 2:40 PM - 3:00 PM PST | Moscone Center, Room 211 (Level 2 South)
Abstract
We report lung cancer detection using liquid biopsy. Machine learning-assisted ATR-FTIR spectroscopy of serum achieved 81% specificity and 79% sensitivity. This method requires no labelling or processing beyond isolating serum from blood and takes less than one minute.
Samples from 52 participants with confirmed lung cancer and 52 samples from participants matched by age, sex and current smoking status were analysed. ATR-FTIR spectroscopy was used to measure 9 μL samples in liquid form.
Specificity and sensitivity were investigated using different machine learning classifiers and figures of merit. Combining measured spectra with medical history and a random forest classifier gave optimum performance.
Our strategy for improving sensitivity and sensitivity and for point-of-care integration will be discussed which may lead in the future to use as a triage for patients to determine which patients require further investigation for lung cancer.
Presenter
David J. Rowe
Univ. of Southampton (United Kingdom)
Dr David J Rowe is Senior Research Fellow in Silicon Photonics at the ORC and Visiting Scientist at the NIHR Southampton Clinical Research Facility at University Hospital Southampton. His research interests are centred on mid-infrared spectroscopy and its clinical applications. Technologically, he is focused on miniaturising devices and microfluidic integration for low-cost sensing. Clinically, he is interested in early cancer detection, drug monitoring and minimally invasive care. Dave has published over 30 journal and conference papers. He has received various awards and scholarships for academic excellence.